Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses the newly available JAK inhibitors for use in a variety of dermatological conditions. Dr. Chovatiya reviews how JAK inhibitors work differently from other agents to reduce inflammation and the benefits that they can have for certain patient populations.
Dr. Dasilva discusses positive results from a recent study published in the Journal of Clinical and Aesthetic Dermatology that assessed the safety and efficacy of JAK inhibitors in a group of elderly patients. Click here to read the full article. Reference:
...
